Literature DB >> 20861331

Enzyme-linked immunosorbent assay for detection of filovirus species-specific antibodies.

Eri Nakayama1, Ayaka Yokoyama, Hiroko Miyamoto, Manabu Igarashi, Noriko Kishida, Keita Matsuno, Andrea Marzi, Heinz Feldmann, Kimihito Ito, Masayuki Saijo, Ayato Takada.   

Abstract

Several enzyme-linked immunosorbent assays (ELISAs) for the detection of filovirus-specific antibodies have been developed. However, diagnostic methods to distinguish antibodies specific to the respective species of filoviruses, which provide the basis for serological classification, are not readily available. We established an ELISA using His-tagged secreted forms of the transmembrane glycoproteins (GPs) of five different Ebola virus (EBOV) species and one Marburg virus (MARV) strain as antigens for the detection of filovirus species-specific antibodies. The GP-based ELISA was evaluated by testing antisera collected from mice immunized with virus-like particles as well as from humans and nonhuman primates infected with EBOV or MARV. In our ELISA, little cross-reactivity of IgG antibodies was observed in most of the mouse antisera. Although sera and plasma from some patients and monkeys showed notable cross-reactivity with the GPs from multiple filovirus species, the highest reactions of IgG were uniformly detected against the GP antigen homologous to the virus species that infected individuals. We further confirmed that MARV-specific IgM antibodies were specifically detected in specimens collected from patients during the acute phase of infection. These results demonstrate the usefulness of our ELISA for diagnostics as well as ecological and serosurvey studies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20861331      PMCID: PMC2976089          DOI: 10.1128/CVI.00170-10

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  35 in total

1.  Immunoglobulin G enzyme-linked immunosorbent assay using truncated nucleoproteins of Reston Ebola virus.

Authors:  T Ikegami; M Saijo; M Niikura; M E Miranda; A B Calaor; M Hernandez; D L Manalo; I Kurane; Y Yoshikawa; S Morikawa
Journal:  Epidemiol Infect       Date:  2003-06       Impact factor: 2.451

2.  Outbreak of Ebola hemorrhagic fever Uganda, August 2000-January 2001.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2001-02-09       Impact factor: 17.586

Review 3.  The pathogenesis of Ebola hemorrhagic fever.

Authors:  A Takada; Y Kawaoka
Journal:  Trends Microbiol       Date:  2001-10       Impact factor: 17.079

4.  Enzyme-linked immunosorbent assays for detection of antibodies to Ebola and Marburg viruses using recombinant nucleoproteins.

Authors:  M Saijo; M Niikura; S Morikawa; T G Ksiazek; R F Meyer; C J Peters; I Kurane
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

5.  Epitopes involved in antibody-mediated protection from Ebola virus.

Authors:  J A Wilson; M Hevey; R Bakken; S Guest; M Bray; A L Schmaljohn; M K Hart
Journal:  Science       Date:  2000-03-03       Impact factor: 47.728

6.  Ebola virus VP40 drives the formation of virus-like filamentous particles along with GP.

Authors:  Takeshi Noda; Hiroshi Sagara; Emiko Suzuki; Ayato Takada; Hiroshi Kida; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

7.  Analysis of linear B-cell epitopes of the nucleoprotein of ebola virus that distinguish ebola virus subtypes.

Authors:  Masahiro Niikura; Tetsuro Ikegami; Masayuki Saijo; Takeshi Kurata; Ichiro Kurane; Shigeru Morikawa
Journal:  Clin Diagn Lab Immunol       Date:  2003-01

8.  Antibody-dependent enhancement of Ebola virus infection.

Authors:  Ayato Takada; Heinz Feldmann; Thomas G Ksiazek; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

9.  Identification of protective epitopes on ebola virus glycoprotein at the single amino acid level by using recombinant vesicular stomatitis viruses.

Authors:  Ayato Takada; Heinz Feldmann; Ute Stroeher; Mike Bray; Shinji Watanabe; Hiroshi Ito; Martha McGregor; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

10.  Large serological survey showing cocirculation of Ebola and Marburg viruses in Gabonese bat populations, and a high seroprevalence of both viruses in Rousettus aegyptiacus.

Authors:  Xavier Pourrut; Marc Souris; Jonathan S Towner; Pierre E Rollin; Stuart T Nichol; Jean-Paul Gonzalez; Eric Leroy
Journal:  BMC Infect Dis       Date:  2009-09-28       Impact factor: 3.090

View more
  54 in total

1.  Clinical aspects of Marburg hemorrhagic fever.

Authors:  Masfique Mehedi; Allison Groseth; Heinz Feldmann; Hideki Ebihara
Journal:  Future Virol       Date:  2011-09       Impact factor: 1.831

2.  Marburg and Ravn Virus Infections Do Not Cause Observable Disease in Ferrets.

Authors:  Gary Wong; Zirui Zhang; Shihua He; Marc-Antoine de La Vega; Kevin Tierney; Geoff Soule; Kaylie Tran; Lisa Fernando; Xiangguo Qiu
Journal:  J Infect Dis       Date:  2018-11-22       Impact factor: 5.226

3.  Distinct Biological Phenotypes of Marburg and Ravn Virus Infection in Macaques.

Authors:  Veronica V Nicholas; Rebecca Rosenke; Friederike Feldmann; Dan Long; Tina Thomas; Dana P Scott; Heinz Feldmann; Andrea Marzi
Journal:  J Infect Dis       Date:  2018-11-22       Impact factor: 5.226

Review 4.  Strategies in Ebola virus disease (EVD) diagnostics at the point of care.

Authors:  Chad T Coarsey; Nwadiuto Esiobu; Ramswamy Narayanan; Mirjana Pavlovic; Hadi Shafiee; Waseem Asghar
Journal:  Crit Rev Microbiol       Date:  2017-04-25       Impact factor: 7.624

5.  Airway delivery of an adenovirus-based Ebola virus vaccine bypasses existing immunity to homologous adenovirus in nonhuman primates.

Authors:  Jason S Richardson; Stéphane Pillet; Alexander J Bello; Gary P Kobinger
Journal:  J Virol       Date:  2013-01-09       Impact factor: 5.103

6.  Development of an antibody capture ELISA using inactivated Ebola Zaire Makona virus.

Authors:  Verena Krähling; Dirk Becker; Cornelius Rohde; Markus Eickmann; Yonca Eroğlu; Astrid Herwig; Romy Kerber; Katharina Kowalski; Júlia Vergara-Alert; Stephan Becker
Journal:  Med Microbiol Immunol       Date:  2015-10-16       Impact factor: 3.402

7.  Inhibition of Marburg virus budding by nonneutralizing antibodies to the envelope glycoprotein.

Authors:  Masahiro Kajihara; Andrea Marzi; Eri Nakayama; Takeshi Noda; Makoto Kuroda; Rashid Manzoor; Keita Matsuno; Heinz Feldmann; Reiko Yoshida; Yoshihiro Kawaoka; Ayato Takada
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

Review 8.  Epidemiology and Management of the 2013-16 West African Ebola Outbreak.

Authors:  M L Boisen; J N Hartnett; A Goba; M A Vandi; D S Grant; J S Schieffelin; R F Garry; L M Branco
Journal:  Annu Rev Virol       Date:  2016-08-15       Impact factor: 10.431

9.  Development of an Immunochromatography Assay (QuickNavi-Ebola) to Detect Multiple Species of Ebolaviruses.

Authors:  Reiko Yoshida; Shino Muramatsu; Hiroshi Akita; Yuji Saito; Miwa Kuwahara; Daisuke Kato; Katendi Changula; Hiroko Miyamoto; Masahiro Kajihara; Rashid Manzoor; Wakako Furuyama; Andrea Marzi; Heinz Feldmann; Aaron Mweene; Justin Masumu; Jimmy Kapeteshi; Jean-Jacques Muyembe-Tamfum; Ayato Takada
Journal:  J Infect Dis       Date:  2016-07-26       Impact factor: 5.226

10.  Efficacy of Vesicular Stomatitis Virus-Ebola Virus Postexposure Treatment in Rhesus Macaques Infected With Ebola Virus Makona.

Authors:  Andrea Marzi; Patrick W Hanley; Elaine Haddock; Cynthia Martellaro; Gary Kobinger; Heinz Feldmann
Journal:  J Infect Dis       Date:  2016-08-05       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.